What is a stock summary page? Click here for an overview.
Business Description
Panbela Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US86664M2061
Share Class Description:
PBLA: Ordinary SharesDescription
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X), which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -3.52 | |||||
| Debt-to-Equity | -0.35 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 25 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 75.49 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.12 | |||||
| 9-Day RSI | 39.69 | |||||
| 14-Day RSI | 43.05 | |||||
| 3-1 Month Momentum % | 27.27 | |||||
| 6-1 Month Momentum % | 20 | |||||
| 12-1 Month Momentum % | -37.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.26 | |||||
| Quick Ratio | 0.26 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -414.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -293.5 | |||||
| ROIC % | -339.04 | |||||
| 3-Year ROIIC % | -206.5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.28 | |||||
| EV-to-Forward-EBIT | -0.17 | |||||
| EV-to-EBITDA | -0.28 | |||||
| EV-to-Forward-EBITDA | -0.17 | |||||
| EV-to-FCF | -0.52 | |||||
| Earnings Yield (Greenblatt) % | -357.14 | |||||
| FCF Yield % | -981.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PBLA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Panbela Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -18.717 | ||
| Beta | 1.87 | ||
| 3-Year Sharpe Ratio | -1.74 | ||
| 3-Year Sortino Ratio | -1.81 | ||
| Volatility % | 69.32 | ||
| 14-Day RSI | 43.05 | ||
| 14-Day ATR ($) | 0.03489 | ||
| 20-Day SMA ($) | 0.363588 | ||
| 12-1 Month Momentum % | -37.76 | ||
| 52-Week Range ($) | 0.3 - 0.69 | ||
| Shares Outstanding (Mil) | 4.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Panbela Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Panbela Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Panbela Therapeutics Inc Frequently Asked Questions
What is Panbela Therapeutics Inc(PBLA)'s stock price today?
The current price of PBLA is $0.33. The 52 week high of PBLA is $0.69 and 52 week low is $0.30.
When is next earnings date of Panbela Therapeutics Inc(PBLA)?
The next earnings date of Panbela Therapeutics Inc(PBLA) is 2025-03-28 Est..
Does Panbela Therapeutics Inc(PBLA) pay dividends? If so, how much?
Panbela Therapeutics Inc(PBLA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers